Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors (vol 14, pg 50, 2008)

被引：0
|
作者：
Kurth, M. A. H.
DiMichele, D.
Sexauer, C.
Sanders, J. M.
Torres, M.
Zappa, S. C.
Ragni, M.
Leonard, N.
机构：
来源：
HAEMOPHILIA | 2008年 / 14卷 / 04期
关键词：
D O I：
10.1111/j.1365-2516.2008.01809.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：878 / 878
页数：1
相关论文
共 50 条
  • [41] Successful tolerization with high von Willebrand factor/factor VIII content ratio concentrate of children with severe haemophilia A and high responding inhibitor
    Platokouki, H.
    Pergantou, H.
    Xafaki, P.
    Komitopoulou, A.
    Aronis, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1133 - 1133
  • [42] Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.
    Mannucci, PM
    Kyrle, PA
    Schulman, S
    Haertel, S
    Lethagen, S
    BLOOD, 2003, 102 (11) : 312A - 312A
  • [43] Efficacy and safety of factor VIII/von Willebrand factor concentrate Haemate P in von Willebrand patients undergoing surgery
    Zotz, R.
    Mandaliev, A.
    Moeller, N.
    Scharf, R.
    HAEMOPHILIA, 2008, 14 : 118 - 118
  • [44] The impact of von Willebrand factor on factor VIII memory immune responses
    Chen, Juan
    Schroeder, Jocelyn A.
    Luo, Xiaofeng
    Shi, Qizhen
    BLOOD ADVANCES, 2017, 1 (19) : 1565 - 1574
  • [45] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Timofeeva, Margarita
    Khayat, Claudia Djambas
    Inati, Adlette
    Robert, Sidonio F., Jr.
    BLOOD, 2023, 142
  • [46] High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia
    Mohren, Martin
    Jentsch-Ullrich, Kathleen
    Koenigsmann, Michael
    Kropf, Siegfried
    Schalk, Enrico
    Lutze, Gerd
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 189 - 195
  • [47] High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia
    Martin Mohren
    Kathleen Jentsch-Ullrich
    Michael Koenigsmann
    Siegfried Kropf
    Enrico Schalk
    Gerd Lutze
    International Journal of Hematology, 2016, 103 : 189 - 195
  • [48] Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A
    van Helden, P. M. W.
    Kaijen, P. H. P.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    van den Berg, H. M.
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 (06) : 892 - 901
  • [49] Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery
    Hay, C. R. M.
    Hellmann, A.
    Dmoszynska, A.
    Baglin, T.
    O'Shaunessey, D.
    Makris, M.
    Shaikh-Zaidi, R.
    Dash, C. H.
    HAEMOPHILIA, 2011, 17 (03) : 428 - 432
  • [50] Von Willebrand factor modulates factor VIII immunogenicity: Comparative study of different factor VIII concentrates in a haemophilia A mouse model
    Behrmann, M
    Pasi, J
    Saint-Remy, JMR
    Kotitschke, R
    Kloff, M
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (02) : 221 - 229
12345